Btg2 mutation induces renal injury and impairs blood pressure control in female rats

Physiol Genomics. 2022 Jul 1;54(7):231-241. doi: 10.1152/physiolgenomics.00167.2021. Epub 2022 May 3.

Abstract

Hypertension (HTN) is a complex disease influenced by heritable genetic elements and environmental interactions. Dietary salt is among the most influential modifiable factors contributing to increased blood pressure (BP). It is well established that men and women develop BP impairment in different patterns and a recent emphasis has been placed on identifying mechanisms leading to the differences observed between the sexes in HTN development. The current work reported here builds on an extensive genetic mapping experiment that sought to identify genetic determinants of salt-sensitive (SS) HTN using the Dahl SS rat. BTG antiproliferation factor 2 (Btg2) was previously identified by our group as a candidate gene contributing to SS HTN in female rats. In the current study, Btg2 was mutated using transcription activator-like effector nuclease (TALEN)-targeted gene disruption on the SSBN congenic rat background. The Btg2 mutated rats exhibited impaired BP and proteinuria responses to a high-salt diet compared with wild-type rats. Differences in body weight, mutant pup viability, skeletal morphology, and adult nephron density suggest a potential role for Btg2 in developmental signaling pathways. Subsequent cell cycle gene expression assessment provides several additional signaling pathways that Btg2 may function through during salt handling in the kidney. The expression analysis also identified several potential upstream targets that can be explored to further isolate therapeutic approaches for SS HTN.

Keywords: TALEN; hypertension; renal; salt sensitivity.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Blood Pressure / genetics
  • Female
  • Humans
  • Hypertension* / drug therapy
  • Immediate-Early Proteins* / genetics
  • Immediate-Early Proteins* / metabolism
  • Immediate-Early Proteins* / therapeutic use
  • Kidney / metabolism
  • Mutation / genetics
  • Rats
  • Rats, Inbred Dahl
  • Sodium Chloride, Dietary
  • Tumor Suppressor Proteins / genetics
  • Tumor Suppressor Proteins / metabolism
  • Tumor Suppressor Proteins / therapeutic use

Substances

  • BTG2 protein, rat
  • Immediate-Early Proteins
  • Sodium Chloride, Dietary
  • Tumor Suppressor Proteins
  • BTG2 protein, human